209 related articles for article (PubMed ID: 37837739)
21. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.
Nagele P; Pal S; Brown F; Blood J; Miller JP; Johnston J
Anesthesiology; 2012 Aug; 117(2):321-8. PubMed ID: 22692379
[TBL] [Abstract][Full Text] [Related]
22. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.
Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin does not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature.
Heemskerk C; Woldman E; Pereboom M; Van der Hoeven R; Mantel-Teeuwisse A; Van Gemeren C; Becker ML
J Pharm Pharm Sci; 2017; 20(1):360-364. PubMed ID: 29145929
[TBL] [Abstract][Full Text] [Related]
25. Electrocardiographic Parameters Indicating Worse Evolution in Patients with Acquired Long QT Syndrome and Torsades de Pointes.
Kukla P; Jastrzębski M; Fijorek K; Stec S; Bryniarski L; Czarnecka D; Baranchuk A
Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):572-579. PubMed ID: 27018992
[TBL] [Abstract][Full Text] [Related]
26. Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.
Lazzerini PE; Cantara S; Bertolozzi I; Accioli R; Salvini V; Cartocci A; D'Errico A; Sestini F; Bisogno S; Cevenini G; Capecchi M; Laghi-Pasini F; Castagna MG; Acampa M; Boutjdir M; Capecchi PL
J Am Heart Assoc; 2022 Jan; 11(1):e023371. PubMed ID: 34935398
[TBL] [Abstract][Full Text] [Related]
27. QT variability during initial exposure to sotalol: experience based on a large electronic medical record.
Weeke P; Delaney J; Mosley JD; Wells Q; Van Driest S; Norris K; Kucera G; Stubblefield T; Roden DM
Europace; 2013 Dec; 15(12):1791-7. PubMed ID: 23787903
[TBL] [Abstract][Full Text] [Related]
28. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
29. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
30. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development.
Redfern WS; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Palethorpe S; Siegl PK; Strang I; Sullivan AT; Wallis R; Camm AJ; Hammond TG
Cardiovasc Res; 2003 Apr; 58(1):32-45. PubMed ID: 12667944
[TBL] [Abstract][Full Text] [Related]
31. Drug-Induced QTc Prolongation: What We Know and Where We Are Going.
Mangona E; Sandonato E; Brothers TN; Pawasauskas J
Curr Drug Saf; 2022; 17(2):100-113. PubMed ID: 34551700
[TBL] [Abstract][Full Text] [Related]
32. QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with "Known Risk of Torsades de Pointes".
Ryan K; Benz P; Zosel A; Farkas A; Theobald J
Cardiovasc Toxicol; 2022 Sep; 22(9):866-877. PubMed ID: 35930218
[TBL] [Abstract][Full Text] [Related]
33. "QT clock" to improve detection of QT prolongation in long QT syndrome patients.
Page A; Aktas MK; Soyata T; Zareba W; Couderc JP
Heart Rhythm; 2016 Jan; 13(1):190-8. PubMed ID: 26334569
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
[TBL] [Abstract][Full Text] [Related]
35. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.
Hasnain M; Vieweg WV
CNS Drugs; 2014 Oct; 28(10):887-920. PubMed ID: 25168784
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic drugs and QT interval prolongation.
Zareba W; Lin DA
Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
[TBL] [Abstract][Full Text] [Related]
37. Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.
Lin YL; Kung MF
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):235-9. PubMed ID: 19145580
[TBL] [Abstract][Full Text] [Related]
38. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
[TBL] [Abstract][Full Text] [Related]
39. Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes.
Othong R; Wattanasansomboon S; Kruutsaha T; Chesson D; Arj-Ong Vallibhakara S; Kazzi Z
Clin Toxicol (Phila); 2019 Apr; 57(4):234-239. PubMed ID: 30260244
[TBL] [Abstract][Full Text] [Related]
40. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
Wei A; Peng J; Gu Z; Li J
Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
